Accuvest Global Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,738
Closed -$282K 102
2021
Q4
$282K Sell
2,738
-2,011
-42% -$186K 0.12% 106
2021
Q3
$412K Buy
4,749
+471
+11% +$39.5K 0.19% 71
2021
Q2
$357K Buy
4,278
+755
+21% +$61.8K 0.18% 67
2021
Q1
$265K Buy
+3,523
New +$257K 0.14% 84
2020
Q3
Sell
-210
Closed -$14K 38
2020
Q2
$14K Buy
+210
New +$13.2K 0.04% 36
2020
Q1
Sell
-180
Closed -$13K 52
2019
Q4
$13K Buy
+180
New +$12.6K 0.03% 42
2018
Q1
Sell
-75
Closed -$5K 99
2017
Q4
$5K Buy
+75
New +$5.45K ﹤0.01% 88
2017
Q1
Sell
-4,820
Closed -$380K 91
2016
Q4
$380K Sell
4,820
-7,820
-62% -$633K 0.34% 35
2016
Q3
$1.13M Buy
12,640
+6,320
+100% +$597K 0.31% 35
2016
Q2
$605K Hold
6,320
0.37% 35
2016
Q1
$656K Buy
6,320
+1,500
+31% +$146K 0.32% 35
2015
Q4
$471K Hold
4,820
0.2% 48
2015
Q3
$465K Hold
4,820
0.21% 46
2015
Q2
$506K Hold
4,820
0.19% 55
2015
Q1
$497K Sell
4,820
-4,820
-50% -$488K 0.19% 54
2014
Q4
$928K Buy
+9,640
New +$849K 0.2% 60

Other funds holding CVS

Accuvest Global Advisors's CVS Position: Q1 2022 in Review

Accuvest Global Advisors sold out of CVS Health (CVS) in Q1 2022, closing a stake of 2,738 shares — an estimated $282K sold.

Accuvest Global Advisors first reported a position in CVS in Q4 2014 and held it in 16 quarters. The position peaked at $1.13M in Q3 2016. 2,365 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

  • Accuvest Global Advisors reported no remaining CVS Health position as of Q1 2022 after selling out during the quarter.
  • Accuvest Global Advisors sold 2,738 CVS Health shares in Q1 2022, an estimated $282K.
  • Accuvest Global Advisors first reported a position in CVS Health in Q4 2014 and held it in 16 quarters.
  • Accuvest Global Advisors's CVS Health position peaked at $1.13M in Q3 2016.
  • 2,365 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on Accuvest Global Advisors's 13F filing for Q1 2022, filed 6 May 2022.